SNIFF - Combo INI+EMPA Trial

NCT05081219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: Insulin (Humulin® R U-100)
DRUG: Empagliflozin 10 MG
DEVICE: Aptar Pharma CPS Intranasal Delivery Device
DRUG: Placebo (Insulin Diluent)
DRUG: Placebo (Capsules)

Sponsor

Wake Forest University Health Sciences